WhatsApp Us
WhatsApp Us

The first case of HyperSight radiotherapy in China

HyperSight technology is a revolutionary cone-beam computed tomography (CBCT) imaging technology. Through the collaborative innovation of hardware and software, it addresses the key bottlenecks in traditional radiotherapy image guidance.

9/16/20252 min read

Core Technological Breakthroughs:

Large-field detector: The imaging range has expanded from the traditional 43cm×43cm to 86cm×43cm, covering complex anatomical regions such as the entire pelvic cavity and avoiding image stitching errors caused by fractional scanning.

High-speed data acquisition system: Adopting a new type of flat-panel detector and image reconstruction algorithm, the scanning time is reduced from 15-60 seconds of traditional equipment to 6 seconds, significantly improving efficiency.

Breakthrough in image quality: Through dual-energy decomposition technology and deep learning-based noise reduction, the image contrast is increased by 40%, reaching a quality close to diagnostic-level CT and simulation positioning images, which can be directly used for target volume delineation and dose calculation.

Real-time dynamic processing capability: Integrated with artificial intelligence algorithms, it can real-time detect changes in tumor morphology (such as position or size deviation) during treatment and immediately trigger the adaptive radiotherapy process without manual intervention.

Global Milestones:

February 2023: Obtained dual FDA/CE certification, becoming the world's first compliant commercial license.

February 2023: Conducted the first clinical treatment at the University of Pennsylvania in the United States, verifying safety and process feasibility.

May 2023: A longitudinal stability study on radiomics of prostate cancer confirmed that 43 features maintained high stability during treatment (ICC>0.9).

January 2026: Upgraded to Halcyon v4.0 at Guangzhou Jinshazhou Hospital in China, marking the first implementation in Asia with the accumulation of treatment experience for over 10,000 cases